Neuroendocrine Tumor G2

specific

A well-differentiated, intermediate-grade epithelial neoplasm with neuroendocrine differentiation. It usually arises from the digestive system, lung, and head and neck.

57

Centers

109

Active Trials

Cancer Funding

Top Centers for Neuroendocrine Tumor G2(57)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
66.7
2
NCI Comprehensive
Active Research Program
66.7
3
NCI Comprehensive
Active Research Program
66.7
466.7
5
NCI Comprehensive
Active Research Program
66.7
6
NCI Comprehensive
Active Research Program
66.7
7
NCI Comprehensive
Active Research Program
66.7
8
NCI Comprehensive
Active Research Program
66.7
9
Active Research Program
66.7
10
NCI Comprehensive
Active Research Program
66.7
11
NCI Clinical
Active Research Program
66.7
12
Active Research Program
66.7
13
NCI Comprehensive
Active Research Program
66.7
14
Active Research Program
66.7
15
Active Research Program
66.7
16
Active Research Program
66.7
17
Active Research Program
66.7
18
NCI Comprehensive
Active Research Program
52.9
19
NCI Comprehensive
Active Research Program
52.9
20
NCI Comprehensive
Active Research Program
52.9
21
NCI Comprehensive
Active Research Program
52.9
22
NCI Comprehensive
Active Research Program
52.9
23
NCI Comprehensive
Active Research Program
52.9
24
NCI Comprehensive
Active Research Program
52.9
25
NCI Clinical
Active Research Program
52.9
26
NCI Comprehensive
Active Research Program
52.9
27
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
52.9
28
NCI Comprehensive
Active Research Program
52.9
29
NCI Comprehensive
Active Research Program
52.9
30
NCI Clinical
Active Research Program
52.9
31
Active Research Program
52.9
32
Active Research Program
52.9
3352.9
34
Active Research Program
52.9
35
Active Research Program
52.9
36
NCI Comprehensive
Active Research Program
37.1
37
NCI Comprehensive
Active Research Program
37.1
38
NCI Comprehensive
Active Research Program
37.1
39
NCI Comprehensive
Active Research Program
37.1
40
NCI Comprehensive
Active Research Program
37.1
41
NCI Comprehensive
Active Research Program
37.1
42
NCI Comprehensive
Active Research Program
37.1
43
NCI Comprehensive
Active Research Program
37.1
44
NCI Comprehensive
Active Research Program
37.1
45
NCI Comprehensive
Active Research Program
37.1
46
NCI Comprehensive
Active Research Program
37.1
47
Active Research Program
37.1
48
NCI Clinical
Active Research Program
37.1
49
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
37.1
50
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
37.1
51
NCI Comprehensive
Active Research Program
37.1
52
Active Research Program
37.1
53
NCI Basic_laboratory
Active Research Program
37.1
54
Active Research Program
37.1
55
Active Research Program
37.1
56
BC CancerVancouver, BC
Active Research Program
37.1
57
Active Research Program
37.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →